A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

NCT05462756 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

730

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Type 2 Diabetes Treated With Insulin

Interventions

DRUG: Insulin Efsitora Alfa
DRUG: Insulin Lispro (U100)
DRUG: Insulin Glargine (U100)

Sponsor

Eli Lilly and Company